Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PCI Biotech Holding ASA 0JGL.L
$2.59
На 18:02, 12 мая 2023
Ключевые показатели
-
Marketcap
96780566.00000000
-
week52high
0.00
-
week52low
0.00
-
Revenue
-
P/E TTM
0
-
Beta
1.89427400
-
EPS
-2.34800000
-
Last Dividend
0.28500000
-
Next Earnings Date
07 мая 2023 г. в 04:59
Описание компании
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии